Stay updated on Daratumumab with Bortezomib/Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page.

Latest updates to the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded: Revision: v3.4.2. Removed: Revision: v3.4.1 and the government funding notice. These are administrative updates that do not modify trial data or eligibility requirements.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding status notice with links to cc.nih.gov and opm.gov. Updated the site to revision v3.4.1 (from v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and updated footer metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'; removed the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.1%

- Check64 days agoChange DetectedPublications section now includes a PubMed entry for the trial (AMN006) with a note that publications are automatically filled from PubMed. The HHS Vulnerability Disclosure section was removed and the revision label updated from v3.3.2 to v3.3.3; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2 on the study page; no substantive content changes to study details or eligibility criteria were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Daratumumab with Bortezomib/Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page.